Crohn's Disease Night Sweats: What They Mean

Night sweats are one of the symptoms people with Crohn's disease volunteer most readily and one of the least studied. They appear in no list of recognised extraintestinal manifestations, they are not counted in any Crohn's disease activity score, and no published study has measured them in Crohn's on their own. The single population figure that exists counted "fever or night sweats" as one item, and found that 24% of people with Crohn's reported one or the other in any three-month period (Singh 2011).

That gap is the reason this page exists. Search for Crohn's night sweats and you will find advice about bamboo sheets, a confident percentage, and a paragraph about inflammation raising your temperature. What you will not find is the thing that actually changes an outcome: an ordered list of what else produces drenching sweats when you have Crohn's, which of those needs a call this week, and what to write down so the question can be answered rather than re-asked. This guide does that, and says plainly where the evidence stops.

The short answer, and the number every page gets slightly wrong

Crohn's disease can plausibly cause night sweats through systemic inflammation, many people with Crohn's report them, and the honest size of that effect is unknown because nobody has measured it separately.

The study everyone is quoting is worth reading carefully. Researchers followed 704 people from the University of Manitoba IBD Research Registry with five surveys over a year, 552 of whom completed all five. In any three-month period, people with Crohn's reported more of almost everything than people with ulcerative colitis: diarrhoea 63% against 38%, fatigue 54% against 33%, abdominal pain 47% against 32%, and fever or night sweats 24% against 15% (Singh 2011).

Note the "or". The questionnaire item bundled fever and night sweats together, so 24% is the proportion reporting either. The proportion with night sweats specifically has to be lower, and the study does not say by how much.

There is a second thing the abstract will not tell you. When the authors listed the symptoms people still had during periods of inactive disease, they named aching joints (17%), fatigue (15%), diarrhoea (13%) and abdominal pain (9%). Fever and night sweats are not in that list (Singh 2011). That absence may mean the figure was low, or it may mean it was not among the items reported. It is not evidence either way, and it would be wrong to read it as proof that sweats stop in remission, because plenty of people describe exactly the opposite.

Night sweats are not an extraintestinal manifestation, and that matters

An extraintestinal manifestation, or EIM, is inflammation caused by inflammatory bowel disease appearing in a specific tissue outside the bowel: joints, eyes, skin, mouth, bile ducts. Our guide to joint pain with Crohn's disease carries the shared explainer of what counts and what does not, and this post will not rebuild it.

Night sweats are in a different category. They are a constitutional or systemic symptom, which is the same family as fever, weight loss and malaise: a whole-body consequence of an immune process rather than that process turning up in a named tissue. That classification is not pedantry, because it explains the measurement vacuum.

When an international group set out to define how extraintestinal manifestations should be assessed in IBD trials, they produced endpoints for specific manifestations: uveitis, peripheral and axial spondyloarthritis, arthralgia and others, each with a view on whether a specialist is needed to confirm the diagnosis (Guillo 2022). Sweating is not among them. That consensus was supported by Johnson and Johnson, Takeda and Pfizer, which is worth knowing when reading any consensus about which outcomes deserve measuring. A dedicated European guideline on extraintestinal manifestations also exists (Gordon 2024); we cite it only for the fact that it exists, because we could not access its full text and it has no abstract, so we cannot tell you what it says about anything.

The practical consequence: if you go looking for evidence about Crohn's night sweats, you will find none, not because the symptom is imaginary but because it fell outside every framework built to count things.

Not one of the scores counts it

Three instruments dominate how Crohn's activity gets recorded, and between them they capture sweating zero times.

Our walkthrough of how to read a Harvey-Bradshaw score goes through those five items and what each is really asking. The relevant point here is what falls outside them. You can have three weeks of drenching sweats, change your bedding nightly, and produce a Harvey-Bradshaw score identical to someone sleeping perfectly well. If your clinic tracks activity by score alone, the symptom is invisible unless you say it out loud.

The base rate problem: how common are night sweats in people who do not have Crohn's?

Very common, and this is the single most important context missing from every page on this topic.

In a cross-sectional study across two primary care research networks, 2,267 adult patients were asked about sweating. 41% reported night sweats within the previous month, made up of 23% with night sweats only and a further 18% with both day and night sweats. Prevalence peaked between ages 41 and 55 in both men and women, and most people had never mentioned it to their doctor even when it was frequent and severe (Mold 2002).

Now hold that against a second study from the same research network. Among 795 primary care patients over 64, only 10% reported being bothered by night sweats, 9% by day sweats and 8% by hot flashes, with 18% reporting at least one of the three (Mold 2004).

Those two figures, 41% and 10%, come from overlapping investigators using the same infrastructure. We cannot fully reconcile them from the published abstracts, and we are not going to pretend otherwise. Two differences are clearly doing work. The first study asked whether night sweats had occurred; the second asked whether the patient was bothered by them, a higher bar. And the second was restricted to people over 64, while the first found the peak in middle age. Consistent with that, the older-patient study found night sweats became less likely with each additional year of age. A systematic review by the same lead author later put the whole published range at 10% among older primary care patients up to 60% among women on an obstetric inpatient unit, and concluded flatly that "the symptom, night sweats, appears to be nonspecific" and that algorithmic approaches to evaluating it are not evidence-based (Mold 2012).

It is not only adults. In a survey of 6,381 primary school children, 11.7% were reported to have weekly night sweats over the past 12 months, associated with sleep-related, respiratory and atopic conditions (So 2012).

The conclusion is uncomfortable but useful. "Do you get night sweats?" is close to a coin flip in the general adult population. So the fact that you get them tells your IBD team almost nothing. What tells them something is the pattern: when it started, whether it is new for you, whether there is a measured temperature, whether it comes with chills, weight change, pain or a lump, and what else changed in the same fortnight.

Why would Crohn's cause them? The mechanism, and how much of it is inference

The mechanism usually offered is plausible and partly supported, and the specific step connecting it to sweating in Crohn's has not been measured.

Fever is not the body losing control of its temperature. It is the body changing its target. Pyrogenic signalling, with interleukin-6 playing several roles, resets the temperature the body defends, and the fever response is an integrated physiological and neuronal circuit conserved across vertebrates for more than 600 million years (Evans 2015). Once the target is raised, you feel cold and shiver until you reach it. When the signal falls, the target drops, you are now too warm for it, and the body sheds heat the fastest way it can, which is by sweating.

Layer the daily rhythm on top. Human body temperature follows a predictable circadian curve, rising through the day to peak in the evening and falling steadily overnight to a minimum around the time of waking (Geneva 2025). An evening temperature peak followed by an overnight fall is, mechanically, a fever that breaks while you are asleep.

That is exactly what people describe. In one r/CrohnsDisease thread asking whether others wake drenched, the most upvoted explanatory reply said it likely means a low-grade fever that breaks overnight, and that nightly fevers were the poster's own reliable sign of a flare (r/CrohnsDisease thread). Several people in a separate thread described waking soaked and then becoming freezing cold, which is the same cycle running in the other direction (r/CrohnsDisease thread).

We should be honest about the join. Nothing above was measured in people with Crohn's disease. Evans and colleagues were reviewing fever immunology broadly; the circadian review is general physiology. The systematic review of night sweats specifically concluded that many questions about causation remain unanswered (Mold 2012). So the mechanism is a well-supported story with a plausible ending, not a measured chain.

Do night sweats warn you before a flare?

Many people say theirs do. There is no published dataset showing it, and if you want a warning sign you will have to build your own rather than borrow one.

What has been measured is adjacent, not identical. In 3,173 people from the Crohn's and Colitis Foundation Partners cohort, among 1,291 whose Crohn's was in remission at baseline, impaired sleep was associated with double the odds of active disease six months later, with an adjusted odds ratio of 2.00 (95% CI 1.45 to 2.76). In ulcerative colitis the same analysis found nothing, with an odds ratio of 1.14 (95% CI 0.75 to 1.74) (Ananthakrishnan 2013). If you have seen "poor sleep predicts relapse in IBD" quoted at you, that is the study, and the effect was present in Crohn's and absent in colitis. Worth knowing which one you have before applying it.

But sleep disturbance is not night sweats. And the link between the two is weaker than it looks: a retrospective review of two sleep laboratories found that patients who reported night sweats did report more daytime fatigue, snoring and restless legs, yet the authors could find no association between subjective night sweats and objective findings on polysomnography (Mold 2008). That was a selected sleep-clinic population, so it is a caution rather than a refutation, but it means you cannot use "I have night sweats" as a proxy for a diagnosable sleep disorder either.

Sleep problems are genuinely common in IBD. A cross-sectional study of 208 patients, 150 with Crohn's, found sleep disorders in 59.6% against 37.7% of 199 healthy controls (Zhang 2024). That study's abstract describes a "higher prevalence among females (63.5%) compared to males (56.9%)", but its own p value for that comparison is 0.476, so it is not a difference the data support. It is a small example of a large habit, and the reason to read numbers rather than sentences.

Our guide on how to tell if you are in a Crohn's flare covers what actually settles the question, and what a high calprotectin with no symptoms means covers the reverse case, where the inflammation is measurable and the feeling is not. Night sweats belong in your log as a candidate personal signal. They do not belong in a sentence that starts "research shows".

The five explanations worth working through, in order of what they change

If you take one thing from this page, take this list, in this order. It is ordered by how much each possibility changes what should happen next, not by how likely it is.

1. A fever you have not measured

This is first because it is cheap to check and because measuring it converts your symptom into data. Among older primary care patients, fever was by far the strongest correlate of night sweats, with an odds ratio of 12.60 (95% CI 6.58 to 24.14), well ahead of muscle cramps, numbness, impaired vision or hearing loss (Mold 2004). A thermometer by the bed is the highest-yield thing you can add to your tracking this week.

2. An abscess or penetrating disease

This is the possibility most worth ruling out, because it is treatable and it does not improve while you wait. In the Olmsted County population-based cohort of 306 people with Crohn's, the cumulative risk of developing a stricturing or penetrating complication was 18.6% at 90 days after diagnosis, 22.0% at one year, 33.7% at five years and 50.8% at 20 years, with ileal involvement and perianal disease the factors associated with progression (Thia 2010).

Health pages frequently state that abscesses affect "up to 30%" of people with Crohn's. We read the source one such page linked, and the sentence there is that the natural history of Crohn's leads to an intra-abdominal or pelvic abscess in approximately 10% to 30% of patients (Haas 2022). Quoting only the top of a range is not wrong, but it is not the same thing, and the range is the honest version.

Two people in the same thread independently traced their worst sweats to abscesses. One described evening fevers from abscesses near the anus that broke overnight and stopped once the abscesses were treated; another replied to the original poster simply that being drenched in sweat could be an abscess forming (r/CrohnsDisease thread). That is not evidence of how common it is. It is a reason the possibility belongs high on your list rather than buried under bedding tips.

3. An infection, made both more likely and harder to spot

If you are on immunosuppressive treatment, the calculation changes. In a case-control study of 100 consecutive IBD patients with opportunistic infections, use of corticosteroids, thiopurines or infliximab each raised the odds individually, and use of two or three of these drugs together gave an odds ratio of 14.5 (95% CI 4.9 to 43) (Toruner 2008). The individual estimate for infliximab was imprecise, with a confidence interval running from 1.2 to 17.1, and the authors said explicitly that the absolute risk of opportunistic infection in IBD remains to be determined. So this is a relative-risk finding about combinations, not a number you can turn into your own odds.

Two specific infections deserve naming.

C. difficile can both mimic and provoke a flare. In an IBD referral centre the infection rate rose from 1.8% of patients in 2004 to 4.6% in 2005, with worse clinical outcomes (Issa 2007). Sweats plus new diarrhoea after a course of antibiotics is a stool test, not a step-up in your Crohn's treatment.

Tuberculosis is the reason latent TB screening happens before anti-TNF treatment. The original signal was 70 reported cases of tuberculosis after infliximab among roughly 147,000 patients treated worldwide, with 48 developing it after three or fewer infusions and 40 having extrapulmonary disease. That paper's own background notes that excess TNF-alpha in tuberculosis may itself cause weight loss and night sweats (Keane 2001).

The modern numbers are reassuring and need reading carefully. A Danish nationwide cohort covering 553,551 person-years found a crude TB incidence of 39.3 per 100,000 person-years in biologic-treated patients against 12.4 in biologic-naive patients, an incidence rate ratio of 3.2 (95% CI 2.0 to 4.9), with risk concentrated overwhelmingly in people who were IGRA-positive (rate ratio 45.0) or born in a country with intermediate or high TB incidence (Kraef 2025). That cohort combined inflammatory bowel disease and inflammatory rheumatic disease, and the published abstract does not break the rate ratio down by condition, so it would be wrong to quote 3.2 as the figure for IBD specifically. A separate US claims study of 20,705 people with IBD on advanced therapies found incidence of 38 per 100,000 person-years on TNF antagonists against 33 on non-TNF biologics, with an adjusted hazard ratio of 1.16 (95% CI 0.41 to 3.31), and concluded that in a low-incidence region the risk is very low and comparable across therapies (Ahuja 2026). Those confidence intervals are extremely wide because the events are extremely few, so the fair reading is "too rare here to distinguish between drugs", not "one drug is safer".

One more wrinkle. Intestinal tuberculosis and Crohn's disease share clinical, endoscopic, imaging and pathological features closely enough that differentiating them is a standing problem, and an erroneous diagnosis in either direction can worsen the course (Cazacu 2026). This matters most if you have lived in or travelled to a high-incidence region. It is a reason to mention travel history when you report sweats, not a reason to doubt your diagnosis.

4. Your medication

Steroids are the drug people name most often in threads, and several people in the sweats threads above attributed their sweats to prednisone or to a fast taper. There is a recognised endocrine basis for problems on the way down: the commonest cause of adrenal suppression is exogenous steroid treatment, now termed glucocorticoid-induced adrenal insufficiency, and weaning from high doses can produce a glucocorticoid withdrawal syndrome that overlaps with it (Nachawi 2024). We could not confirm from that review that sweating is a defined feature of either, so treat this as a reason to raise a taper with your team rather than as a sourced explanation. Never change a steroid dose or stop a taper on your own, whatever a forum says.

Fever on thiopurines is documented and uncommon. In a single-centre cohort of 98 people starting a thiopurine, 64 adverse events occurred in 48 patients (49%), of which two were fevers of unknown origin (2%), alongside 21 cases of neutropenia, 19 of raised transaminases, 13 of digestive intolerance, 6 of acute pancreatitis and 3 of phototoxicity; 29.4% had to stop treatment (Grau 2023). Those figures add up exactly to the reported total, which is more than can be said for many abstracts. Worth noting the conclusion of that paper describes thiopurines as "a safe drug with few AEs" while its own results show half the cohort had an adverse event and nearly a third stopped treatment; the reassurance is about severity and timing, not frequency. A larger cohort of 722 patients on thiopurines found 81 (11.2%) had at least one severe adverse event, with fever of unknown origin accounting for 3 of those 81 (Frisancho 2025).

Antidepressants come up repeatedly in these threads, including one person who said their sweats had worsened since starting sertraline. There is supporting evidence in a different population: among 413 primary care patients aged 65 to 94, SSRIs were associated with night sweats with an odds ratio of 3.01 (95% CI 1.26 to 7.19), alongside angiotensin receptor blockers (3.44) and thyroid hormone supplements (2.53) (Mold 2015). Read that with the design in mind: 35 medication classes were tested and three reached significance, which is barely above what chance alone would produce across 35 comparisons. The authors themselves said the ARB and thyroid findings warrant further study. The SSRI link has case reports behind it too, so it is the most credible of the three, but this is one small cross-sectional study in older adults, not a finding in people with Crohn's.

5. Something that has nothing to do with Crohn's

A Crohn's diagnosis is very good at swallowing other explanations. Several are worth naming.

Hormonal change. Vasomotor symptoms, which is the clinical term covering hot flushes and night sweats, are highly prevalent across most societies, with the rate varying widely by region and menopausal stage (Freeman 2007). This is directly relevant because a systematic review of 15 studies found that women with IBD experience menopause earlier than healthy controls, that most reported no change in IBD symptoms after menopause while a minority worsened, and that the overall evidence base is thin (Kale 2025). In one of the threads above, a reply to a poster asking about drenched nights suggested perimenopause depending on age, which was among the more clinically sensible answers given. Our post on why Crohn's gets worse around your period covers the cyclical side of this.

Sleep-disordered breathing. Obstructive sleep apnoea is more common in IBD: in a large multi-network analysis, prevalence was 7.8% in ulcerative colitis and 7.2% in Crohn's against 4.3% in people without IBD (Hoffman 2022). Those are electronic health record diagnoses rather than adjudicated sleep studies, and the odds ratio for UC was reported as 1.9 with a confidence interval of 1.86 to 1.94, a band so narrow it reflects the size of the database rather than the precision of the diagnosis. Hold that alongside the sleep-lab finding of no objective association with night sweats (Mold 2008). One reply in the first thread flagged sleep apnoea as a common cause of waking sweaty, which is a reasonable prompt for someone who also snores or is sleepy in the day.

Thyroid. Overactive thyroid causes sweating, and thyroid hormone replacement was one of the three drug classes associated with night sweats in the study above. The IBD link itself is less settled than commonly claimed: a review focused on children and adolescents concluded that current data do not show a unanimous association between Graves' disease or Hashimoto's thyroiditis and IBD (Calcaterra 2025). So thyroid function is a fair thing to have checked. It is not a known IBD complication.

Alcohol. In men, greater alcohol use was one of the factors associated with day-and-night sweats in the 2002 primary care study (Mold 2002). Our guide to alcohol and Crohn's disease covers the rest of that picture.

The lymphoma question, and the arithmetic nobody does for you

Almost certainly no, and the reason is arithmetic rather than reassurance. This section exists because the question is in every one of these threads, usually unasked, and because a page that dodges it leaves people to search alone at 3am.

Drenching night sweats are a recognised lymphoma symptom. In the modern staging framework, the A and B suffixes for symptoms are retained only for Hodgkin lymphoma rather than for non-Hodgkin lymphomas (Cheson 2014). Meanwhile thiopurines do raise lymphoma risk in IBD. Both statements are true. Neither tells you what to do.

Here is what does. In CESAME, a prospective French cohort of 19,486 people with IBD followed by 680 gastroenterologists for a median of 35 months, there were 23 new lymphoproliferative disorders in total. The rates were 0.90 per 1,000 patient-years in people currently receiving thiopurines, 0.20 in people who had discontinued, and 0.26 in people who had never received them, giving an adjusted hazard ratio of 5.28 (95% CI 2.01 to 13.9) (Beaugerie 2009).

Now subtract the baseline, which is the step almost nobody does. The excess is 0.90 minus 0.26, which is 0.64 extra cases per 1,000 patient-years: roughly one additional case for every 1,560 years of treatment. A more than fivefold relative risk sitting on a very small absolute one. Both facts are real, and only one of them is usually quoted. That cohort was funded by French public research programmes and non-profit organisations rather than industry, which is worth knowing when weighing a drug-risk estimate in either direction.

A later meta-analysis makes the same point about how estimates get inflated. Across 18 studies, the pooled standardised incidence ratio for lymphoma on thiopurines was 4.92 (95% CI 3.10 to 7.78). But it ranged from 2.80 (1.82 to 4.32) across eight population-based studies to 9.24 (4.69 to 18.2) across ten referral-centre studies. The pooled figure is therefore a blend of two very different populations, and the one that resembles ordinary care is the lower of the two. Risk became significant after one year of exposure, was raised in current users (SIR 5.71) but not former users (SIR 1.42, 95% CI 0.86 to 2.34), and did not appear to persist after stopping (Kotlyar 2015). That study was supported by intramural NIH funding.

There is one rare lymphoma worth knowing about specifically because it is so concentrated. A systematic review of hepatosplenic T-cell lymphoma in IBD gathered 36 patients from published reports and the FDA's spontaneous reporting system. Twenty had received infliximab plus a thiopurine and 16 a thiopurine alone; of 31 with known sex, only two were female, and 27 of the 30 with known age were under 35. There were no reported cases in people receiving anti-TNF therapy alone (Kotlyar 2011). Because that is a case series with no denominator, it cannot give you a rate at all. It tells you where the cases clustered, which is why the combination is weighed differently in young men.

For balance: two cohorts of people over 65, followed for an average of 7.3 and 7.5 years, found that patients reporting night sweats on a primary care health questionnaire were not more likely to die or to die sooner after adjusting for age, sex, body mass index, education and income, and the same held for those with more severe sweats (Mold 2010). That study was in older adults and says nothing about any individual, but it is the closest thing to a direct answer to "how much should I worry about this symptom in general", and the answer is: less than the internet suggests, and enough to get it looked at.

What to record, so the question becomes answerable

Record a number, a count and a context. Those three things convert an unmeasured symptom into something your team can act on, and they take about thirty seconds a night.

Do not send a month of raw entries. Our guide to what a clinician will actually read from a symptom tracker covers why a forty-page export gets ignored and what a one-page version looks like, and what to ask your gastroenterologist about Crohn's covers the conversation itself.

Clairop is built around this kind of handover: it logs symptoms alongside meals, builds your activity score from answers you have already given, and produces a one-page visit report showing the score trend, bowel pattern, medication adherence and lab results with the source of each number stated. It does not diagnose anything and it is not a substitute for your IBD team's assessment. The method page explains how it decides when a pattern has enough data behind it to be worth showing you at all.

A worked example: two people, six weeks, the same complaint

Both of these people would post the same question. The answers are not close.

Person A. Crohn's affecting the terminal ileum, in remission for two years on a thiopurine. Over three weeks she starts waking at around 3am with her top soaked, twice needing to change. She buys a thermometer and finds 37.9, 38.2 and 38.0 on three of those nights, taken between 1am and 3am. Her stool count is unchanged at two a day, no blood, but she has a new dull ache low on the right side after eating and has lost 2kg without trying. She calls her IBD nurse in week two rather than week six, lists the temperatures, the ache and the weight, and mentions the thiopurine. She is seen the same week, has bloods and a calprotectin sent, and imaging is arranged to look for penetrating disease. The point is not what the scan showed. The point is that three numbers moved her from "I am sweaty" to a specific question somebody could answer.

Person B. Crohn's affecting the colon, in remission for four years, no immunosuppressant, aged 49. She has been waking damp most nights for six months, occasionally soaked. Her temperature is 36.7 and 36.9 on the two nights she measures. Stool count is at her usual baseline, no blood, no pain, no weight change. What has changed: her periods have become irregular, she started an SSRI five months ago, and she has begun sleeping through her partner's snoring complaints about her own. Her log makes the pattern look nothing like inflammation, which is itself the useful result. She takes it to her GP rather than her IBD team, and the conversation is about perimenopause, the timing of the antidepressant and whether a sleep assessment is worth it. Nobody chases her calprotectin, because there is no reason to.

Same symptom, same word, entirely different work. The log is what separated them, and the temperature did most of the separating.

Myths worth retiring

Myth: "24% of people with Crohn's get night sweats." The source figure is for fever or night sweats reported in any three-month period (Singh 2011). The night-sweat-only figure has never been published.

Myth: "Night sweats mean your Crohn's is active." They may. They also occur in 41% of general primary care patients in a given month (Mold 2002), and in Crohn's communities people describe them persisting through documented remission and disappearing on treatment in roughly equal measure. Only a test tells you about inflammation.

Myth: "Night sweats are an extraintestinal manifestation." They are a constitutional symptom, and they are absent from the international consensus on measuring extraintestinal manifestations in trials (Guillo 2022).

Myth: "If your blood count is normal it is not lymphoma." Diagnosis and staging rest on imaging and tissue (Cheson 2014). A normal count does not settle it.

Myth: "Thiopurines make lymphoma likely." They raise a small absolute risk. The excess in the largest prospective cohort was 0.64 cases per 1,000 patient-years (Beaugerie 2009), and the pooled relative estimates are inflated by referral-centre studies (Kotlyar 2015). Weighing this belongs with your IBD team, alongside the risks of untreated inflammation.

Myth: "Better bedding is the answer." Cooling sheets, a fan, a towel on the mattress and a spare set of pyjamas are what people in these threads overwhelmingly recommend, and they genuinely make the nights more bearable. They also make it easier to stop asking why. Do both: improve the night, and get the cause looked at.

Myth: "It went away for me when I did X, so X works." Threads carry suggestions ranging from fasting after 6pm to taking many times the labelled dose of an over-the-counter antidiarrhoeal. Never take more of any medicine than its label says on the strength of a forum comment. Nothing on this page is a treatment recommendation.

When to see a doctor

Contact your IBD team promptly rather than waiting for a routine appointment if you have night sweats plus any of the following:

• A measured temperature above your normal, especially repeatedly
• New or worsening abdominal pain, a tender lump, or a swollen abdomen
• Any new pain, swelling or discharge around the anus
• Unintended weight loss
• New or increasing blood in your stool, or a clear rise in stool frequency above your baseline
• New diarrhoea after a course of antibiotics, or a recent stomach bug
• A new cough that is not settling, particularly if you take an anti-TNF medicine or have lived in or travelled to a country with a high tuberculosis rate
• Feeling breathless, dizzy or unusually pale, which can point to anaemia

See a doctor promptly, and say these words in this order, if you have drenching night sweats persisting for several weeks together with unexplained weight loss, recurring fevers, or new lumps in your neck, armpit or groin. That combination is what gets properly assessed, and getting assessed is how it stops being a 3am search.

Seek urgent same-day help for a high fever with severe abdominal pain, a swollen tender abdomen, vomiting with no stool or wind passing, or feeling faint with a racing heart.

And if you are simply exhausted by nights like this, that is worth raising too. Fatigue and disturbed sleep travel together in Crohn's, and our posts on Crohn's fatigue that persists in remission and explaining Crohn's fatigue to other people cover the part nobody measures either.

The honest bottom line

Night sweats in Crohn's disease sit in an odd position: constantly reported, rarely studied, and absent from every instrument built to count what Crohn's does to you. The mechanism is plausible. The prevalence figure everybody quotes is a composite. The general-population base rate is so high that the symptom alone barely narrows anything down.

What that means for you is not "ignore it". It means the work is in the details rather than the label. Buy a thermometer. Count the clothing changes instead of rating the feeling. Note whether it is nights only. Write down what else changed in the same month. Then take that page, with your stool count and any weight change, to the people who can order a calprotectin, a stool test, a scan or a thyroid panel. A symptom that no score measures is one you have to measure yourself, and once it has numbers attached it stops being untreatable vagueness and becomes a question with a next step.

If none of the explanations fits and the sweats continue, that is a legitimate answer too, and it happens: the systematic review of this symptom concluded that in most cases the cause is unknown (Mold 2012). Knowing it is not an abscess, not an infection, not your thyroid and not your lymph nodes is worth the effort it took to find out. Browse our other Crohn's disease guides for the symptoms that do have numbers behind them, including mouth ulcers and brain fog, where the same "reported everywhere, measured almost nowhere" problem turns up in a different form.